GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS
- Conditions
- Rhinitis, Allergic, Perennial
- Interventions
- Drug: placebo FFNSDrug: FPNSDrug: FFNSDrug: placebo FPNS
- First Posted Date
- 2007-08-22
- Last Posted Date
- 2016-12-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 360
- Registration Number
- NCT00519636
- Locations
- 🇺🇸
GSK Investigational Site, San Antonio, Texas, United States
Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
- Conditions
- Hepatitis B Vaccine
- Interventions
- Biological: Engerix™-B Kinder
- First Posted Date
- 2007-08-22
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 301
- Registration Number
- NCT00519649
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany
Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
- Conditions
- Infections, Papillomavirus
- Interventions
- Procedure: Blood samplingProcedure: Collection of cervical specimenBiological: Cervarix
- First Posted Date
- 2007-08-20
- Last Posted Date
- 2016-12-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 433
- Registration Number
- NCT00518336
- Locations
- 🇧🇷
GSK Investigational Site, São Paulo, Brazil
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2007-08-20
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 361
- Registration Number
- NCT00518115
- Locations
- 🇩🇴
GSK Investigational Site, Santo Domingo, Dominican Republic
A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.
- Conditions
- Seasonal Allergic RhinitisSinusitis
- First Posted Date
- 2007-08-17
- Last Posted Date
- 2013-09-02
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 21
- Registration Number
- NCT00517946
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects
- Conditions
- Healthy SubjectsInfections, Bacterial
- Interventions
- Drug: Sugar Pill
- First Posted Date
- 2007-08-17
- Last Posted Date
- 2012-03-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 68
- Registration Number
- NCT00517673
- Locations
- 🇦🇺
GSK Investigational Site, Adelaide, South Australia, Australia
A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)Rheumatoid ArthritisAtherosclerosis
- First Posted Date
- 2007-08-17
- Last Posted Date
- 2010-10-14
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT00517543
- Locations
- 🇺🇸
GSK Investigational Site, Tacoma, Washington, United States
Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects
- First Posted Date
- 2007-08-17
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 23
- Registration Number
- NCT00517634
- Locations
- 🇬🇧
GSK Investigational Site, Manchester, United Kingdom
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease
- Conditions
- Hepatitis C, Chronic
- First Posted Date
- 2007-08-15
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 687
- Registration Number
- NCT00516321
- Locations
- 🇬🇧
GSK Investigational Site, Plymouth, United Kingdom
Lamotrigine Extended-Release In Elderly Patients With Epilepsy
- First Posted Date
- 2007-08-15
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 122
- Registration Number
- NCT00516139
- Locations
- 🇺🇸
GSK Investigational Site, Milwaukee, Wisconsin, United States